Alimentiv Inc. is a public contract research organization (CRO) specializing in gastrointestinal (GI) clinical trials, medical imaging, precision medicine, statistical services, and clinical consulting for pharmaceutical and biotechnology companies. The company originally operated as Robarts Clinical Trials, part of Western University, starting in 1986 before its acquisition and rebranding as Alimentiv in 2020.
Headquartered in London, Ontario, Canada, Alimentiv employs over 700 people and operates worldwide, with a presence in Canada, the United States, Europe, Asia-Pacific, and Latin America. The organization serves more than 64 countries globally and collaborates with leading scientists and companies to advance GI treatment options for patients.
Alimentiv’s capabilities include patient recruitment, clinical trial design, medical imaging, histopathology, precision medicine services, and statistical analysis. In 2021, Alimentiv expanded its offerings by acquiring McDougall Scientific Ltd., which specializes in statistical analysis and clinical trial design, and launching AcelaBio, a commercial research laboratory in San Diego, providing histopathology and precision medicine services for global clinical trials.
Alimentiv’s mission revolves around innovative clinical research to improve treatments for gastrointestinal and liver diseases. Its services enable pharmaceutical and biotechnology organizations to conduct complex clinical trials efficiently and with advanced scientific support. The company integrates patient recruitment, imaging innovations, and statistical expertise to support drug development in GI health.
Overall, Alimentiv is a specialized CRO dedicated to enhancing clinical research quality and advancing medical breakthroughs in the gastrointestinal therapeutic area, leveraging a global footprint and multidisciplinary expertise to benefit patients worldwide.